Dihydroorotate dehydrogenase inhibitors
Abstract:
Disclosed are compounds, compositions and methods for treating diseases, disorders, or medical conditions that are affected by the modulation of DHODH. Such compounds are represented by Formula (I) as follows:




wherein R1, R2, R3, R4, X, and Y are defined herein.
Public/Granted literature
Information query
Patent Agency Ranking
0/0